arginine vasopressin has been researched along with 2019 Novel Coronavirus Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Gareeb, AI; Al-Kuraishy, HM; Alshammari, EM; Atanu, FO; Batiha, GE; Qusti, S | 1 |
| Botigué, T; Canet Velez, O; Cemeli Sánchez, T; Lavedán Santamaría, A; Masot, O; Roca, J | 1 |
1 review(s) available for arginine vasopressin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Arginine vasopressin and pathophysiology of COVID-19: An innovative perspective.
Topics: Arginine Vasopressin; COVID-19; COVID-19 Drug Treatment; Drug Discovery; Humans; Inflammation; SARS-CoV-2; Water-Electrolyte Imbalance | 2021 |
1 other study(ies) available for arginine vasopressin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Diagnostic Concordance between the Visual Analogue Anxiety Scale (VAS-A) and the State-Trait Anxiety Inventory (STAI) in Nursing Students during the COVID-19 Pandemic.
Topics: Anxiety; Arginine Vasopressin; COVID-19; Cross-Sectional Studies; Humans; Pandemics; Students, Nursing | 2022 |